Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
Core EBITDA Growth

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Growth(%) -7.1420.1417.5458.34-8.24

What is the latest Core EBITDA Growth ratio of MANKIND PHARMA ?

The latest Core EBITDA Growth ratio of MANKIND PHARMA is -7.14 based on Mar2023 Consolidated results.
Year Core EBITDA Growth
Mar2023-7.14
Mar202220.14
Mar202117.54
Mar202058.34
Mar2019-8.24

How is Core EBITDA Growth of MANKIND PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2023 -7.14
Negative
Mar2022 20.14
14.82
Mar2021 17.54
-69.93
Mar2020 58.34
Positive
Mar2019 -8.24 -

Other Financial Ratios of MANKIND PHARMA


Compare Core EBITDA Growth ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹85,970.8 Cr 1.5% -8.1% 53.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹350,339.0 Cr -0.5% -3.8% 50.8% Stock Analytics
CIPLA ₹116,930.0 Cr -2% 2% 53.3% Stock Analytics
DIVIS LABORATORIES ₹114,416.0 Cr 1.3% 8.7% 26.8% Stock Analytics
ZYDUS LIFESCIENCES ₹100,694.0 Cr -5.5% 1.3% 99.9% Stock Analytics
DR REDDYS LABORATORIES ₹96,546.9 Cr -1.7% -8% 28.9% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.5%

-8.1%

53.1%

SENSEX

-1.9%

-0.7%

18.3%


You may also like the below Video Courses